England
NHS England will not offer “life-changing” migraine drug
The National Institute for Health and Care Excellence (NICE) has once again sparked controversy and debate amongst healthcare institutions after it rejected a “life-changing” migraine drug for use in the NHS in England. Erenumab, also known as Aimovig, was first…